Valuation: GC Genome Corporation

Market Cap 19TCr 14Cr 12Cr 12Cr 11Cr 20Cr 1.36TCr 20Cr 140.62Cr 54Cr 690.4Cr 53Cr 52Cr 2.25TCr P/E 2026 *
-
P/E 2027 * -
Enterprise Value 13Cr 97.93T 86.14T 81.2T 74.08T 1L 94L 1L 10L 4L 47.84L 4L 4L 1.56Cr EV / Sales 2026 *
3.44x
EV / Sales 2027 * 2.55x
Free-Float
49.55%
Yield 2026 *
-
Yield 2027 * -
1 day+12.21%
1 week+21.55%
Current month+38.18%
1 month+51.76%
3 months+82.18%
6 months+10.54%
Current year+19.94%
1 week 6,580
Extreme 6580
8,350
1 month 5,120
Extreme 5120
8,350
Current year 4,100
Extreme 4100
9,520
1 year 4,100
Extreme 4100
9,520
3 years 4,100
Extreme 4100
15,180
5 years 4,100
Extreme 4100
15,180
10 years 4,100
Extreme 4100
15,180
Manager TitleAgeSince
Chief Executive Officer 57 26/03/2020
Director of Finance/CFO 50 27/03/2025
Comptroller/Controller/Auditor 45 29/03/2024
Director TitleAgeSince
Director/Board Member 57 30/03/2023
Date Insider Type Main position Quantity % Market Cap. Importance
17/06/25 Free

Chief Executive Officer

1,69,285 -
17/06/25 Free 1,38,250 --
Change 5-day change 1-year change 3-year change Capi.($)
+12.21%+21.55%+0.99% - 14Cr
+4.61%+11.60%+149.40%+792.16% 5.63TCr
+1.63%-4.27%+10.60%+50.60% 2.47TCr
-0.58%-4.23%-13.57%-38.65% 661.52Cr
-2.60%-8.32%-5.60%+158.28% 576.14Cr
+1.92%+3.46%+17.79%+67.66% 335.6Cr
+3.85%-15.69%-22.54%+2,364.62% 254.09Cr
+6.54%-1.66%+148.54%+60.99% 235.88Cr
+17.77%+2.56%+35.30%+45.12% 232.3Cr
+1.10%+8.21%+0.72%-52.89% 197.8Cr
Average +4.64%+1.14%+32.16%+383.10% 1.06TCr
Weighted average by Cap. +3.37%+5.02%+84.78%+499.51%

Financials

2026 *2027 *
Net sales 3.9TCr 2.85Cr 2.51Cr 2.36Cr 2.16Cr 4.03Cr 273.46Cr 4.06Cr 28Cr 11Cr 139.18Cr 11Cr 10Cr 452.9Cr 4.88TCr 3.56Cr 3.14Cr 2.96Cr 2.7Cr 5.04Cr 342.18Cr 5.08Cr 35Cr 14Cr 174.15Cr 13Cr 13Cr 566.7Cr
Net income - -
Net Debt -5.94TCr -4.34Cr -3.82Cr -3.6Cr -3.28Cr -6.14Cr -416.5Cr -6.19Cr -43Cr -17Cr -211.98Cr -16Cr -16Cr -689.79Cr -6.88TCr -5.03Cr -4.42Cr -4.17Cr -3.8Cr -7.11Cr -482.41Cr -7.17Cr -50Cr -19Cr -245.52Cr -19Cr -18Cr -798.95Cr
Logo GC Genome Corporation
GC Genome Corp is a Korea-based company principally engaged in the provision of genome testing and analysis services. The Company is principally engaged in the provision of prenatal and newborn screening genetic testing services, cancer patient precision diagnosis genetic testing services, precision diagnosis genetic testing service for patients with rare diseases, health checkup test services as well as others.
Employees
-
Date Price Change Volume
23/26/23 ₩8,180.00 +12.21% 11,88,856
22/26/22 ₩7,290.00 +7.68% 8,08,005
21/26/21 ₩6,770.00 -1.88% 82,408
18/26/18 ₩6,900.00 -1.43% 1,48,168
17/26/17 ₩7,000.00 +4.01% 4,37,733

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A340450 Stock